MacroGenics, Inc. (MGNX)
NASDAQ: MGNX · Real-Time Price · USD
3.700
-0.170 (-4.39%)
Nov 4, 2024, 4:00 PM EST - Market closed
MacroGenics Employees
MacroGenics had 339 employees as of December 31, 2023. The number of employees decreased by 18 or -5.04% compared to the previous year.
Employees
339
Change (1Y)
-18
Growth (1Y)
-5.04%
Revenue / Employee
$120,997
Profits / Employee
-$402,277
Market Cap
232.07M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
ModivCare | 21,200 |
SOPHiA GENETICS | 430 |
Anika Therapeutics | 357 |
2seventy bio | 274 |
Editas Medicine | 265 |
Precigen | 202 |
Enanta Pharmaceuticals | 145 |
Inventiva | 123 |
MGNX News
- 5 days ago - MacroGenics Announces Leadership Transition - GlobeNewsWire
- 6 days ago - MacroGenics Announces Date of Third Quarter 2024 Financial Results Conference Call - GlobeNewsWire
- 10 days ago - Rigrodsky Law, P.A. Is Investigating MacroGenics, Inc. On Behalf of Shareholders - Accesswire
- 13 days ago - MacroGenics Enters Into Agreement With TerSera Therapeutics for the Sale of MARGENZA® - Business Wire
- 5 weeks ago - Shareholders of MacroGenics, Inc. Should Contact The Gross Law Firm Before September 24, 2024 to Discuss Your Rights – MGNX - GlobeNewsWire
- 5 weeks ago - The Schall Law Firm Invites Investor Participation In A Securities Fraud Case Against MacroGenics, Inc. - Accesswire
- 5 weeks ago - MGNX Investors Have Opportunity to Join MacroGenics, Inc. Fraud Investigation with the Schall Law Firm - Business Wire
- 6 weeks ago - MacroGenics, Inc. Investors: Please contact the Portnoy Law Firm to recover your losses. September 24, 2024 Deadline to file Lead Plaintiff Motion - GlobeNewsWire